Home > Healthcare & Medical Devices > U.S. Dialysis Market

U.S. Dialysis Market Size By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis), Industry Analysis Report, Regional Outlook (East North Central {Illinois, Indiana, Michigan, Ohio, Wisconsin}, West South Central {Arkansas, Louisiana, Oklahoma, Texas}, South Atlantic {Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington D.C.}, North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East South Central {Alabama, Kentucky, Mississippi, Tennessee}, West North Central {Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming}), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI5091
  • Published Date: Apr 2022
  • Report Format: PDF

Industry Overview

U.S. Dialysis Market size was valued at around USD 33.5 billion in 2021 and is expected to witness 6.5% CAGR from 2022 to 2028 owing to the rise in geriatric population, increase in healthcare expenditure, and high disposable income. Moreover, surge in funding for the development of new products will provide a profitable scenario for the U.S. market.

U.S. dialysis market outlook

Get more details on this report - Request Free Sample PDF

Increasing burden of renal diseases in the U.S. is the key factor driving the market growth. The demand for dialysis therapy will increase as the elderly population are susceptible to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Furthermore, favourable reimbursement scenario, technological advancements in dialysis products, together with improved healthcare facilities, will further boost the U.S. dialysis market sales.

The impact of COVID-19 on the U.S. dialysis industry is observed to be moderate. COVID-19 infection is majorly a respiratory disease, but it has also shown to affect kidneys as well, damaging the organ to cause an acute renal infection (AKI). Major players of the dialysis business ramped up their production. For instance, in 2020 amid pandemic Baxter increased the manufacturing of fluids and sets required in dialysis procedure.

The company provided CRRT machines, fluids and sets to help healthcare facilities to address patient needs globally. This ensured that the product shortage can be alleviated. Similarly, many medical device companies have doubled up their production and supply in response to the emerging needs of patient and healthcare sector.

Dialysis is used to remove waste products from the blood, such as urea and creatinine, that are produced when the kidneys do not work properly. People with chronic renal failure are benefited from the procedure. The procedure is most commonly used to treat end-stage renal illness and kidney transplantation. Blood is filtered, excessive fluids and toxins are eliminated, and electrolyte balance is maintained in the blood with the help of this procedure. Haemodialysis and peritoneal dialysis are the two types of dialysis available.

Shortage of kidney donors for transplantation will fuel the market growth over the years

The shortage of kidney donors for transplantation in the U.S. continues to be a major issue. Every year, around many deceased donor kidneys are rejected due to anomalies discovered in procurement biopsies. Kidney transplant is a time-consuming surgery, and the kidney that is transplanted must be accurately examined to avoid post-transplant complications. There is often a danger of renal failure. As a result, the number of kidney donors has been steadily declining in recent years. This results in a significant dependence and need for dialysis therapy among patients.

According to Penn Medicine data, in the U.S. the shortage of kidneys for transplantation has emerged as public health crisis. Nearly 90,000 patients in the country are on waiting list for kidney transplants. However, only about 20,000 transplants are performed annually. Each year, around 5,000 people on the waiting list of transplants die without getting it. Thus, the shortage of kidney donors in the U. S. will have a favourable impact for dialysis market growth, as it will raise demand for dialysis therapy in the region.

Rising cases of ESRD will pave the way for the hemodialysis market expansion over the forecast period

U.S. dialysis market by type

Get more details on this report - Request Free Sample PDF

Based on type, the U.S. dialysis market is divided into peritoneal dialysis and hemodialysis. Out of these two, the hemodialysis segment accounted for around 88% market share in 2021. The segmental growth is high as hemodialysis treatment helps to balance minerals including salt, calcium, and potassium, that helps to lower blood pressure. Additionally, hemodialysis uses arteriovenous (AV) fistula, as it is the standard vascular access used to access a person’s blood. And also requires lesser time compared to peritoneal dialysis.

Moreover, rising cases of chronic kidney disease will contribute towards the market expansion. For instance, according to the 2021 Centers for Disease Control and Prevention fact sheet, chronic kidney disease affects roughly 15% of the adult population, i.e., 37 million population in the U.S. This disease is primarily caused by diabetes and heart disease. As a result, rising diabetes cases and high blood pressure prevalence are expected to contribute the U.S. dialysis market share.

Rising adoption of dialysis treatment will fuel the market for dialysis consumables and will offer significant industry growth opportunities 

U.S. dialysis market product and services

Get more details on this report - Request Free Sample PDF

Based on product and services, the U.S. dialysis market is fragmented into equipment, consumables, and services. The consumables segment held over USD 4.2 billion in revenue size in 2021 and is poised to experience a high growth rate over the analysis timeframe. Consumables such as catheters offers maximum patient safety, enhancing the market expansion.

Similarly, tunneled hemodialysis catheters (a tunneled hemodialysis catheter is a special tube made of plastic used for hemodialysis treatment) offer uncomplicated and needle-free connection to the dialysis circuit and eliminates cannulation site complications and provide simple insertion technique that can be performed by many different interventional specialists. Furthermore, consumables such as dialyzers, blood tubes, access products, and other items have a greater replacement rate and are commonly utilised during hemodialysis therapy.

Home dialysis segment is anticipated to show a significant market growth

The U.S. dialysis market based on end-use is bifurcated into home dialysis and in-center dialysis. The home dialysis segment accounted for over 14.5% market share in 2021. People prefer home dialysis because it provides a higher quality of life, lower travel costs, more flexibility, and easier patient mobility. Further, elderly population with kidney disease prefers home dialysis treatment, that is anticipated to boost the overall market progression.

Increasing patient population in West South-Central region will bolster the market progression

U.S. dialysis market by region

Get more details on this report - Request Free Sample PDF

The West South-Central region accounted for USD 4.5 billion in 2021 due to surging demand for dialysis. Favourable government initiatives will favour the market growth. For instance, in August 2021, in Texas a new legislation was passed to support emergency preparation for kidney treatment. The law improves and prioritize dialysis services in the event of an unexpected natural disaster and when patient care is at stake.

Also, for the first time in the Senate Bill (SB) 1876, allowed dialysis patients to be transported to the emergency room by emergency ambulance directly to the outpatient center instead of the emergency room, if necessary. This action helps to rescue the emergency department of patients whose only medical condition is life-sustaining dialysis. In addition, presence of numerous dialysis centers and new modern care facilities in these states continues to drive regional dialysis market growth.

Presence of large industry players in the U.S. will foster the market growth

Some of the prominent market players operating in the U.S. dialysis industry include Fresenius Medical Care, Becton Dickinson, Baxter, DaVita Inc., Rogosin Institute, B. Braun Melsungen AG, Asahi Kasei Corporation, Nipro Corporation, Sanderling Renal Services, Medtronic, Rockwell Medical Inc., Satellite Healthcare, Toray Industries Inc., and U.S. Renal Care, Inc. These industry participants are implementing various business growth strategies to sustain market competition in the U.S. dialysis market.

Some of the recent industry developments:

  • In January 2022, U.S. Renal Care (USRC), announced that it has further expanded its in-center hemodialysis services in Southwest Florida with the opening of four additional facilities. The company's customer base will grow as a result of this strategic move, and its market position will improve.
  • In June 2021, DaVita launched DaVita Care Connect, a mobile health platform built exclusively for home dialysis users, has launched virtual support groups. This virtual assistance will let the company connect with a big number of patients who are receiving dialysis treatment at home. Such strategies undertaken by country helped strengthen its market position.

The U.S. dialysis market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Type

  • Hemodialysis 
  • Peritoneal dialysis

By Product and Services

  • Equipment
    • Dialysis machines
    • Water treatment systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Access products
    • Concentrates
    • Others
  • Services
    • Acute dialysis
    • Chronic dialysis

By End-use

  • In-center dialysis
  • Home dialysis

The above information is provided for the following regions and states:

By Country

  • East North Central
    • Illinois
    • Indiana
    • Michigan
    • Ohio
    • Wisconsin
  • West South Central
    • Arkansas
    • Louisiana
    • Oklahoma
    • Texas
  • South Atlantic
    • Delaware
    • Florida
    • Georgia
    • Maryland
    • North Carolina
    • South Carolina
    • Virginia
    • West Virginia
    • Washington, D.C.
  • Northeast
    • Connecticut
    • Maine
    • Massachusetts
    • New Hampshire
    • Rhode Island
    • Vermont
    • New Jersey
    • New York
    • Pennsylvania
  • East South Central
    • Alabama
    • Kentucky
    • Mississippi
    • Tennessee
  • West North Central
    • Iowa
    • Kansas
    • Minnesota
    • Missouri
    • Nebraska
    • North Dakota
    • South Dakota
  • Pacific Central
    • Alaska
    • California
    • Hawaii
    • Oregon
    • Washington
  • Mountain States
    • Arizona
    • Colorado
    • Utah
    • Nevada
    • New Mexico
    • Idaho
    • Montana
    • Wyoming


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The dialysis industry share in the U.S. slated to surpass USD 52.5 billion by 2028 and will observe a 6.5% CAGR between 2022 and 2028 owing to escalating disposable incomes, expanding geriatric population, and growing healthcare spending in the country.

The regional industry revenue from consumables surpassed USD 4.2 billion in 2021 and will grow with the increasing usage of catheters to provide maximum patient safety.

Home dialysis held over 14.5% of the regional dialysis market share in 2021 owing to the expanding elderly population with kidney diseases.

The dialysis market in the West South-Central region generated a revenue of over USD 4.5 billion in 2021 driven by the surging demand for dialysis and the presence of favorable government initiatives.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 15
  • Tables & Figures: 785
  • Countries covered: 8
  • Pages: 330

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount